BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muhammad JS, Saheb Sharif-Askari N, Cui ZG, Hamad M, Halwani R. SARS-CoV-2 Infection-Induced Promoter Hypomethylation as an Epigenetic Modulator of Heat Shock Protein A1L (HSPA1L) Gene. Front Genet 2021;12:622271. [PMID: 33679887 DOI: 10.3389/fgene.2021.622271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Muhammad JS, Elghazali G, Shafarin J, Mohammad MG, Abu-qiyas A, Hamad M. SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients. Biochemical and Biophysical Research Communications 2022;631:138-45. [DOI: 10.1016/j.bbrc.2022.09.083] [Reference Citation Analysis]
2 Laplantine E, Chable-Bessia C, Oudin A, Swain J, Soria A, Merida P, Gourdelier M, Mestiri S, Besseghe I, Bremaud E, Neyret A, Lyonnais S, Favard C, Benaroch P, Hubert M, Schwartz O, Guerin M, Danckaert A, Del Nery E, Muriaux D, Weil R. The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling. iScience 2022;25:105066. [PMID: 36093378 DOI: 10.1016/j.isci.2022.105066] [Reference Citation Analysis]
3 Liu L, Zhang Y, Chen Y, Zhao Y, Shen J, Wu X, Li M, Chen M, Li X, Sun Y, Gu L, Li W, Wang F, Yao L, Zhang Z, Xiao Z, Du F. Therapeutic prospects of ceRNAs in COVID-19. Front Cell Infect Microbiol 2022;12:998748. [DOI: 10.3389/fcimb.2022.998748] [Reference Citation Analysis]
4 Saik OV, Klimontov VV. Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity? IJMS 2022;23:7247. [DOI: 10.3390/ijms23137247] [Reference Citation Analysis]
5 Zhuang Z, Zhong X, Chen Q, Chen H, Liu Z. Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19. Front Pharmacol 2022;13:857730. [PMID: 35721149 DOI: 10.3389/fphar.2022.857730] [Reference Citation Analysis]
6 Muhammad JS, Siddiqui R, Khan NA. COVID-19 and alcohol use disorder: putative differential gene expression patterns that might be associated with neurological complications. Hosp Pract (1995) 2022;:1-7. [PMID: 35686663 DOI: 10.1080/21548331.2022.2088183] [Reference Citation Analysis]
7 Caldera-Crespo LA, Paidas MJ, Roy S, Schulman CI, Kenyon NS, Daunert S, Jayakumar AR. Experimental Models of COVID-19. Front Cell Infect Microbiol 2021;11:792584. [PMID: 35096645 DOI: 10.3389/fcimb.2021.792584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
8 Li S, Zhou W, Li D, Pan T, Guo J, Zou H, Tian Z, Li K, Xu J, Li X, Li Y. Comprehensive characterization of human–virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs. Computational and Structural Biotechnology Journal 2022;20:1244-53. [DOI: 10.1016/j.csbj.2022.03.002] [Reference Citation Analysis]
9 Ahmad S, Wen Y, Irudayaraj JMK. PFOA induces alteration in DNA methylation regulators and SARS-CoV-2 targets Ace2 and Tmprss2 in mouse lung tissues. Toxicol Rep 2021;8:1892-8. [PMID: 34853776 DOI: 10.1016/j.toxrep.2021.11.014] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Muhammad JS, Siddiqui R, Khan NA. SARS-CoV-2: Can sunlight exposure reduce the risk of developing severe consequences of COVID-19? Comput Biol Chem 2021;96:107602. [PMID: 34823125 DOI: 10.1016/j.compbiolchem.2021.107602] [Reference Citation Analysis]
11 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
12 Muhammad JS, Siddiqui R, Khan NA. COVID-19: Is There a Link between Alcohol Abuse and SARS-CoV-2-Induced Severe Neurological Manifestations? ACS Pharmacol Transl Sci 2021;4:1024-5. [PMID: 33860221 DOI: 10.1021/acsptsci.1c00073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Muhammad JS, Siddiqui R, Khan NA. COVID-19: Does SARS-CoV-2 Modulate Acanthamoeba Epigenetics to Enhance Survival and Transmission in the Environment? ACS Pharmacol Transl Sci 2021;4:1021-3. [PMID: 33860220 DOI: 10.1021/acsptsci.1c00059] [Cited by in F6Publishing: 1] [Reference Citation Analysis]